Medistim

Board/Management Information • Sep 18, 2014

Medistim appoints new President for its US operation

Medistim appoints new President for its US operation

(Oslo, September 18th, 2014) Medistim ASA (OSE:

MEDI), a Norwegian company that develops and

commercializes medical equipment for use within

cardiac, vascular and transplant surgery, announces

that they have appointed Mike Farbelow as the new

President of Medistim USA Inc.

Mr. Farbelow has extensive experience selling

surgical devices and managing sales teams in the

medical device market. He served for many years with

Smith & Nephew's endoscopy division as the director

of sales for the central region. His most recent

position prior to joining Medistim was with Richard

Wolf USA, where he served as their national sales

manager in spinal endoscopy.

Mike Farbelow holds a management degree from the

University of Minnesota, Carlson School of

Management. He joined Medistim in May 2012 as Vice

President of the US sales team. Since January 2014 he

has been Acting President of Medistim USA Inc.

Medistim is pleased to announce that with effect of

today, Mike Farbelow is appointed President of

Medistim USA Inc.

The US represents the largest market for Medistim's

products with 33 % of the world market. In the US

about 80 % of the coronary artery bypass surgeries

are performed with no other quality assurance of

blood flow other than the surgeons experience by

feeling pulse on the vessels using finger palpation.

It is clinically proven that this method is not

reliable. It is therefore a large potential and need

for Medistim's products in the US. Medistim has large

ambitions in the US market. So far, Medistim has

achieved a market penetration of more than 13% of the

total market of approximately 240.000 bypass surgery

procedures performed annually.

For more information, contact:

President & CEO, Kari E. Krogstad, Medistim ASA

Tel: + 47 918 38 110

Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA

Tel: + 47 906 59 940

Email: thomas.jakobsen@medistim.com

About Medistim

Medistim was established in 1984, and has a track

record of profitable growth over the past >10 years.

The company is a pioneer within its segment, and

continues to invest in new product development.

Medistim has wholly owned subsidiaries with sales

organizations in the US, Germany, Denmark, UK and

Norway, in addition to the around 50 distributors in

Europe, Asia, Middle East, Africa and South

America. For more information, visit the Medistim

home page: www.Medistim.com